| Product Name | MF | CAS | Details |
|---|
| Bilastine Impurity 14 | C32H46N4O3 | 2767509-00-0 | Details |
| (7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol | C27H41BrO2 | 875573-67-4 | Details |
| Methyl 3-ethynyl-4-methylbenzoate | C11H10O2 | 1255099-13-8 | Details |
| Tirofiban IMpurity (4,4'-Dipyridyl-1,5-Pentane) | C15H18N2 | 25382-33-6 | Details |
| (R)-3-Methylpiperazin-2-one | C5H10N2O | 922178-61-8 | Details |
| 3-Methyl-1,2,4-thiadiazole-5-carbohydrazide | C4H6N4OS | 1375066-73-1 | Details |
| N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester | C16H16N4O4S | 1869118-24-0 | Details |
| Tirofiban hydrochloride Impurity 6 | C17H27NO7S2 | 2250244-31-4 | Details |
| (S)-3-(Methylamino)-1-(2-thienyl)-1-propanol | C8H13NOS | 116539-55-0 | Details |
| Pralsetinib | C27H32FN9O2 | 2097132-94-8 | Details |
| 2-Thiophenecarboxylic acid, 5-chloro-, 1-(aminomethyl)-2-[[4-(3-oxo-4-morpholinyl)phenyl]amino]ethyl ester | C18H20ClN3O4S | 2484747-45-5 | Details |
| Benzeneacetic acid, 4-[2-[4-[1-(2-methoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl- | C27H35N3O3 | 2767508-98-3 | Details |
| 5-chloro-4-hydroxy-2-methoxybenzoic acid | C8H7ClO4 | 86720-98-1 | Details |
| 5-Chloro-2-nitrobenzoic acid | C7H4ClNO4 | 2516-95-2 | Details |
| Keto Bisoprolol | C18H29NO5 | 864544-37-6 | Details |
| 7-Benzyl-2,4-dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyriMidine | C14H13Cl2N3 | 1059735-34-0 | Details |
| 2-ThiophenecarboxaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- | C19H19N3O5S | 1310316-95-9 | Details |
| (1S,5R,6S)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate | C14H22O4 | 204254-96-6 | Details |
| Pazopanib Impurity 9 | C15H17N5O | 1296888-47-5 | Details |
| 3-Nitrobenzoic acid | C7H5NO4 | 121-92-6 | Details |
| 2,6-difluoro-3,5-diMethoxybenzenaMine | C19H18ClN3O4S | 2382664-60-8 | Details |
| Trimecaine | C15H24N2O | 616-68-2 | Details |
| N-Butylsulfonyl-L-tyrosine | C13H19NO5S | 149490-60-8 | Details |
| Cyclohexanecarboxylic acid, 4-(1,6-dihydro-4-methyl-6-oxo-2-pyrimidinyl)-1-methoxy-, methyl ester, cis- | C14H20N2O4 | 2778223-48-4 | Details |
| Pyridine, 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)-, 1-oxide | C7H6BrN5O | 700370-45-2 | Details |
| 2-(Chloromethyl)-4-methoxy-3-methylpyridine hydrochloride | C8H11Cl2NO | 86604-74-2 | Details |
| Shikimic acid | C7H10O5 | 138-59-0 | Details |
| 4-Acetamido-2-methoxybenzoic acid | C10H11NO4 | 55304-05-7 | Details |
| tert-Butyl 2,4-dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine-7-carboxylate | C12H15Cl2N3O2 | 916420-27-4 | Details |
| Bilastine Impurity 19 | C24H29N3O2 | 2099128-83-1 | Details |
| methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate | C15H15NO5 | 2469735-68-8 | Details |
| 2,4-Diethoxypyrimidine | C8H12N2O2 | 20461-60-3 | Details |
| Olmesartan medoxomil impurity I | C29H28N6O5 | 879562-26-2 | Details |
| 5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole | C11H9N3S | 172152-53-3 | Details |
| (R)-tert-butyl2-methyl-3-oxopiperazine1-carboxylate | C10H18N2O3 | 1629229-82-8 | Details |
| 3-(2-Amino-2-oxoethyl)-hexanoic acid | C8H15NO3 | 2650545-85-8 | Details |
| Adipic dihydrazide | C6H14N4O2 | 1071-93-8 | Details |
| 3,5-dichloro-4-methoxybenzoic acid | C8H6Cl2O3 | 37908-97-7 | Details |
| 1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione | C13H9F4IN2O2 | 1150560-54-5 | Details |
| Ethyl (3R,4R,5S)-4-N-Acetyl(1,1-dimethylethyl)amino-5-N,N-diallylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate monohydrochloride | C26H45ClN2O4 | 651324-08-2 | Details |
| 3-Ethynylimidazo[1,2-b]pyridazine | C8H5N3 | 943320-61-4 | Details |
| 7-Bromo-2-methyl-1H-benzoimidazole-5-carboxylic acid | C9H7BrN2O2 | 1378255-43-6 | Details |
| N-Butylsulfonyl-O-(4-(4-pyridinyl)butyl)-L-tyrosine | C22H30N2O5S | 149490-61-9 | Details |
| (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine dihydrochloride | C10H12ClFN4 | 1980023-97-9 | Details |
| Sildenafil EP IMpurity B | C22H30N6O5S | 1094598-75-0 | Details |
| 3-Chloro-2-nitrobenzoic acid | C7H4ClNO4 | 4771-47-5 | Details |
| Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-, methyl ester | C29H39N3O3 | 1181267-38-8 | Details |
| 4-Amino-5-chloro-2-methoxybenzoic acid | C7H6ClNO3 | 21386-95-8 | Details |
| M-NIFEDIPINE | C17H18N2O6 | 21881-77-6 | Details |
| (7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate | C34H49F5O3S | 875573-69-6 | Details |
| Ponatinib Hydrochloride | C29H28ClF3N6O | 1114544-31-8 | Details |
| 2,6-difluoro-3,5-diMethoxybenzenaMine | C8H9F2NO2 | 651734-54-2 | Details |
| N-succinylglycine | C6H7NO4 | 5626-41-5 | Details |
| 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-Methyl Ester | C16H16N2O6 | 74936-72-4 | Details |
| 7-Hydroxyquinolinone | C9H7NO2 | 70500-72-0 | Details |
| (S)-4-Propylpyrrolidin-2-one | C7H13NO | 930123-38-9 | Details |
| Benzeneacetic acid, 4-[2-[4-[1-(2-hydroxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl- | C26H33N3O3 | 202189-83-1 | Details |
| 3-Nitrobenzaldehyde | C7H5NO3 | 99-61-6 | Details |
| Cisplatin Impurity 5; Nedaplatin Impurity C | 20115-65-6 | Details |
| 5-(2-PYRIDYL)-1,2-DIHYDROPYRIDIN-2-ONE | C10H8N2O | 381233-78-9 | Details |
| (7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol 17-acetate | C29H43BrO3 | 875573-66-3 | Details |
| S-(4,4,5,5,5-Pentafluoropentyl)isothiourea methanesulfonate | C7H13F5N2O3S2 | 1107606-68-7 | Details |
| 7-(Benzyloxy)-3-bromo-1,2-dihydronaphthalene | C17H15BrO | 722536-73-4 | Details |
| (2R,3S)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile | C13H12F2N4O | 1286729-93-8 | Details |
| R-Tirofiban | C22H36N2O5S | 158808-86-7 | Details |
| 4-CHLOROSULFONYLPHENYLPIVALATE | C11H13ClO4S | 150374-99-5 | Details |
| 2-(diethylamino)-N-(2,4,6-trimethylphenyl)acetamide monohydrochloride | C15H25ClN2O | 1027-14-1 | Details |
| Metoclopramide Impurity 20 | C8H7Cl2NO3 | 1279870-17-5 | Details |
| L-Tyrosine, O-(butylsulfonyl)-, hydrochloride (1:1) | C13H20ClNO5S | 2250244-29-0 | Details |
| 5-(2-Sulfanylidene-3H-1,3-thiazol-4-yl)thiophene-2-carboxamide | C8H6N2OS3 | 52560-89-1 | Details |
| N-Ethyl-2-(4-formylphenyl)-acetamide | C11H13NO2 | 2477812-42-1 | Details |
| 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | C11H10F3N3 | 641571-11-1 | Details |
| N-(2-Bromo-5-methoxyphenyl)-acetamide | C9H10BrNO2 | 123027-99-6 | Details |
| (S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine | C9H15NOS | 132335-44-5 | Details |
| 4-(4-Methylpiperazinomethyl)-3-(trifluoromethyl)aniline | C13H18F3N3 | 694499-26-8 | Details |
| Sacubitril Impurity | C23H27NO4 | 1015037-46-3 | Details |
| Cisplatin Impurity 5; Nedaplatin Impurity E | H8N5O5Pt2+ | 62048-58-2 | Details |
| (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | C16H20BrNO3 | 1428243-26-8 | Details |
| Bilastine N-Oxide | C28H37N3O4 | 2069238-47-5 | Details |
| 4-Pentylpyridine | C10H15N | 2961-50-4 | Details |
| Bilastine Impurity 20 | C36H43N3O4 | 2411093-91-7 | Details |
| (3S)-3-(2-Amino-2-oxoethyl)-hexanoic acid | C8H15NO3 | 1262340-22-6 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||